NEO-201 is a humanized IgG1 mAb that binds to core 1 and/or extended core 1 O-glycans expressed by human cancer cells (including different ovarian cancer subtypes), as well as non-cancerous CD15<sup>+</sup> granulocytes and immunosuppressive cells. This evidence concerns the gene FUT4 and ovarian carcinoma.